April 16, 2010 / 12:34 PM / 10 years ago

UPDATE 1-Molecular Insight gets more time to talk to creditors

* Says gets 30-day extension from its bond holders

* Says talks related to restructuring of debt to continue

* Shares up 6 pct before the bell

April 16 (Reuters) - Molecular Insight Pharmaceuticals Inc MIPI.O said it received a 30-day extension of its waiver agreement with its bond holders, sending its shares up as much as 6 percent in pre-market trade.

The extension will allow its talks with bondholders, related to restructuring of its outstanding debt, to continue, the biopharmaceutical company said in a statement.

The term of the waiver is extended until May 18, it said.

In March, the company said its auditors had expressed doubts on its ability to continue as a going concern, partly due to recurring losses from its operations. [ID:nSGE62F0HC]

Shares of the company closed at $2.73 Thursday on Nasdaq. (Reporting by Shailesh Kuber in Bangalore; Editing by Gopakumar Warrier)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below